{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:21:27Z","timestamp":1794334887689,"version":"4.9.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.lfs.2024.123245","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T22:58:49Z","timestamp":1731884329000},"page":"123245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The role of ABCG2 in health and disease: Linking cancer therapy resistance and other disorders"],"prefix":"10.1016","volume":"360","author":[{"given":"Nahla E.","family":"El-Ashmawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada M.","family":"Al-Ashmawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1106-4072","authenticated-orcid":false,"given":"Omnia B.","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4539-8940","authenticated-orcid":false,"given":"Naglaa F.","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.123245_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2022.11.001","article-title":"ABC transporters: human disease and pharmacotherapeutic potential","author":"Moore","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2024.123245_bb0010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev-biochem-011520-105201","article-title":"Structural and mechanistic principles of ABC transporters","volume":"89","author":"Thomas","year":"2020","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.lfs.2024.123245_bb0015","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jebm.12434","article-title":"ATP-binding cassette (ABC) transporters in cancer: a review of recent updates","volume":"14","author":"Wang","year":"2021","journal-title":"J. Evid. Based Med."},{"key":"10.1016\/j.lfs.2024.123245_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114628","article-title":"Updated chemical scaffolds of ABCG2 inhibitors and their structure-inhibition relationships for future development","volume":"241","author":"Moinul","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2024.123245_bb0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12986-020-00478-4","article-title":"The impact of ATP-binding cassette transporters on metabolic diseases","volume":"17","author":"Ye","year":"2020","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.lfs.2024.123245_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1517\/17425255.2013.742063","article-title":"Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications","volume":"9","author":"Schnepf","year":"2013","journal-title":"Expert Opin. Drug Metabo. Toxicol."},{"key":"10.1016\/j.lfs.2024.123245_bb0035","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1007\/s00018-021-03901-y","article-title":"Multidrug efflux transporter ABCG2: expression and regulation","volume":"78","author":"Kukal","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0040","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.3390\/cancers13184675","article-title":"VKNG-1 antagonizes ABCG2-mediated multidrug resistance via p-AKT and Bcl-2 pathway in colon cancer: in vitro and in vivo study","volume":"13","author":"Narayanan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2024.123245_bb0045","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2024.123245_bb0050","first-page":"5337","article-title":"A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance","volume":"58","author":"Allikmets","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2024.123245_bb0055","first-page":"8","article-title":"Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes","volume":"59","author":"Miyake","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2024.123245_bb0060","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics15020542","article-title":"Interplay of breast cancer resistance protein (Bcrp\/Abcg2), sex, and fed state in oral pharmacokinetic variability of furosemide in rats","volume":"15","author":"Sharma","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2024.123245_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bcp.2017.10.004","article-title":"BCRP\/ABCG2 and high-alert medications: biochemical, pharmacokinetic, pharmacogenetic, and clinical implications","volume":"147","author":"Hira","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123245_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11101-020-09703-7","article-title":"Medicinal plants and phytochemicals against multidrug-resistant tumor cells expressing ABCB1, ABCG2, or ABCB5: a synopsis of 2 decades","volume":"20","author":"Efferth","year":"2021","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.lfs.2024.123245_bb0075","article-title":"An in-silico analysis predicting the impact of coding single nucleotide polymorphisms (SNPs) in the human multidrug pump ABCG2","volume":"38","author":"Bora","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.lfs.2024.123245_bb0080","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3390\/ijms22041935","article-title":"Identification of two dysfunctional variants in the ABCG2 urate transporter associated with pediatric-onset of familial hyperuricemia and early-onset gout","volume":"22","author":"Toyoda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/17425255.2021.1876661","article-title":"ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?","volume":"17","author":"Bruckmueller","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.lfs.2024.123245_bb0090","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1002\/1873-3468.13921","article-title":"What monomeric nucleotide binding domains can teach us about dimeric ABC proteins","volume":"594","author":"Ford","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2024.123245_bb0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.20892\/j.issn.2095-3941.2019.0284","article-title":"ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance","volume":"17","author":"Muriithi","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.lfs.2024.123245_bb0100","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/bph.14991","article-title":"3D structure of the transporter ABCG2-What\u2019s new?","volume":"177","author":"Eckenstaler","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123245_bb0105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83976","article-title":"Nucleotide binding is the critical regulator of ABCG2 conformational transitions","volume":"12","author":"Gy\u00f6ngy","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.lfs.2024.123245_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/molecules28020495","article-title":"A structure-based view on ABC-transporter linked to multidrug resistance","volume":"28","author":"Huang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2024.123245_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/17425255.2020.1732348","article-title":"Transcription factor-mediated regulation of the BCRP\/ABCG2 efflux transporter: a review across tissues and species","volume":"16","author":"Gorczyca","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.lfs.2024.123245_bb0120","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3390\/genes12071068","article-title":"Posttranscriptional regulation of the human ABCG2 multidrug transporter protein by artificial mirtrons","volume":"12","author":"Schamberger","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.lfs.2024.123245_bb0125","article-title":"Mammalian ABCG-transporters, sterols and lipids: to bind perchance to transport?","volume":"1866","author":"Kerr","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.lfs.2024.123245_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114346","article-title":"Targeting breast cancer resistance protein (BCRP\/ABCG2): functional inhibitors and expression modulators","volume":"237","author":"Zattoni","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2024.123245_bb0135","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/dmd.119.089953","article-title":"Epigenetic regulation of multidrug resistance protein 1 and breast cancer resistance protein transporters by histone deacetylase inhibition","volume":"48","author":"You","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2024.123245_bb0140","first-page":"1678","article-title":"The PI3K\/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma","volume":"41","author":"Wang","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2024.123245_bb0145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/jop.13050","article-title":"Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma","volume":"49","author":"Lu","year":"2020","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.lfs.2024.123245_bb0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12986-021-00583-y","article-title":"Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K\/Akt pathway","volume":"18","author":"Liu","year":"2021","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.lfs.2024.123245_bb0155","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/cells12071056","article-title":"ABCB1 and ABCG2 overexpression mediates resistance to the phosphatidylinositol 3-kinase inhibitor HS-173 in cancer cell lines","volume":"12","author":"Wu","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2024.123245_bb0160","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fphar.2019.00208","article-title":"Inhibitors of human ABCG2: from technical background to recent updates with clinical implications","volume":"10","author":"Toyoda","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123245_bb0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/biomedicines12010111","article-title":"ATP-binding cassette subfamily G member 2 in acute myeloid leukemia: a new molecular target?","volume":"12","author":"Damiani","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2024.123245_bb0170","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/s41467-021-23071-6","article-title":"Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance","volume":"12","author":"Giddings","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.123245_bb0175","first-page":"1607","article-title":"A review on ATP binding cassette (ABC) transporters","volume":"5","author":"Mamo","year":"2017","journal-title":"Int. J. Pharma. Res. Health Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00018-019-03186-2","article-title":"Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter","volume":"77","author":"Z\u00e1mb\u00f3","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0185","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3390\/ijms22062786","article-title":"Medically important alterations in transport function and trafficking of ABCG2","volume":"22","author":"Homolya","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0190","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s43440-020-00139-6","article-title":"Intestinal drug transporters in pathological states: an overview","volume":"72","author":"Drozdzik","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.lfs.2024.123245_bb0195","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1021\/acs.chemrev.0c00659","article-title":"Structure and function of hepatobiliary ATP binding cassette transporters","volume":"121","author":"Kroll","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.lfs.2024.123245_bb0200","first-page":"173","article-title":"Pharmacologic inducers of the uric acid exporter ABCG2 as potential drugs for treatment of gouty arthritis","volume":"15","author":"Ristic","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0205","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1177\/0271678X20965500","article-title":"Complete inhibition of ABCB1 and ABCG2 at the blood\u2013brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1\/ABCG2 substrate [11C] erlotinib","volume":"41","author":"Tournier","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.lfs.2024.123245_bb0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.placenta.2017.01.125","article-title":"Down-regulation of the placental BCRP\/ABCG2 transporter in response to hypoxia signaling","volume":"51","author":"Francois","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.lfs.2024.123245_bb0215","doi-asserted-by":"crossref","first-page":"9884","DOI":"10.3390\/ijms25189884","article-title":"The ABCG2 transporter affects plasma levels, tissue distribution and milk secretion of lumichrome, a natural derivative of riboflavin","volume":"25","author":"Mill\u00e1n-Garc\u00eda","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2022.11658","article-title":"ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells","volume":"24","author":"Murakami","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2024.123245_bb0225","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/trf.13515","article-title":"Expression levels of ABCG2 on cord red blood cells and study of fetal anemia associated with anti-Jr (a)","volume":"56","author":"Fujita","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.lfs.2024.123245_bb0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/17425255.2019.1591373","article-title":"ABCG2\/BCRP: variants, transporter interaction profile of substrates and inhibitors","volume":"15","author":"Safar","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.lfs.2024.123245_bb0235","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s11095-017-2127-1","article-title":"Transmembrane domain single-nucleotide polymorphisms impair expression and transport activity of ABC transporter ABCG2","volume":"34","author":"Sj\u00f6stedt","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2024.123245_bb0240","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbrc.2018.06.157","article-title":"Polymorphisms of ABCG2 and its impact on clinical relevance","volume":"503","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.123245_bb0245","doi-asserted-by":"crossref","first-page":"20222","DOI":"10.1074\/jbc.RA119.008347","article-title":"Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs","volume":"294","author":"Zhang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.123245_bb0250","doi-asserted-by":"crossref","DOI":"10.1080\/17425255.2024.2362184","article-title":"Understanding the impact of ABCG2 polymorphisms on drug pharmacokinetics: focus on rosuvastatin and allopurinol","author":"Kasten","year":"2024","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.lfs.2024.123245_bb0255","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1124\/dmd.118.083030","article-title":"Polymorphisms of the multidrug pump ABCG2: a systematic review of their effect on protein expression, function, and drug pharmacokinetics","volume":"46","author":"Heyes","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2024.123245_bb0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/PGPM.S105854","article-title":"ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches","volume":"10","author":"Cleophas","year":"2017","journal-title":"Pharmacogenomics Personalized Med."},{"key":"10.1016\/j.lfs.2024.123245_bb0265","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41467-020-16525-w","article-title":"The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion","volume":"11","author":"Hoque","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2024.123245_bb0270","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acn3.167","article-title":"ABCG2 variant has opposing effects on onset ages of Parkinson\u2019s disease and gout","volume":"2","author":"Matsuo","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.lfs.2024.123245_bb0275","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/FPC.0000000000000305","article-title":"PharmGKB summary: very important pharmacogene information for ABCG2","volume":"27","author":"Fohner","year":"2017","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.lfs.2024.123245_bb0280","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ng.1070","article-title":"Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior","volume":"44","author":"Saison","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lfs.2024.123245_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5348\/100047Z02YO2019RA","article-title":"Variations of three single nucleotide polymorphisms in ABCG2 modify Jra expression","volume":"9","author":"Ogiyama","year":"2019","journal-title":"Int. J. Blood Transf. Immunohematology."},{"key":"10.1016\/j.lfs.2024.123245_bb0290","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bbrc.2013.12.119","article-title":"Impact of genetic variability in the ABCG2 gene on ABCG2 expression, function, and interaction with AT1 receptor antagonist telmisartan","volume":"443","author":"Deppe","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2024.123245_bb0295","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.apsb.2019.01.007","article-title":"Development of precision medicine approaches based on inter-individual variability of BCRP\/ABCG2","volume":"9","author":"Chen","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2024.123245_bb0300","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/ijms18010104","article-title":"Pharmacogenetic foundations of therapeutic efficacy and adverse events of statins","volume":"18","author":"Arrigoni","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0305","doi-asserted-by":"crossref","first-page":"648407","DOI":"10.3389\/fphar.2021.648407","article-title":"Clinically-relevant ABC transporter for anti-cancer drug resistance","volume":"12","author":"Xiao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123245_bb0310","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/pharmaceutics14061131","article-title":"Strategies and mechanism in reversing intestinal drug efflux in oral drug delivery","volume":"14","author":"Lu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2024.123245_bb0315","doi-asserted-by":"crossref","first-page":"6","DOI":"10.20517\/cdr.2018.02","article-title":"How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?","volume":"1","author":"Jaramillo","year":"2018","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.lfs.2024.123245_bb0320","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/acs.molpharmaceut.9b00658","article-title":"Interactions of oral molecular excipients with breast cancer resistance protein, BCRP","volume":"17","author":"Zou","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.lfs.2024.123245_bb0325","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.foodres.2016.12.010","article-title":"Mucus interactions with liposomes encapsulating bioactives: interfacial tensiometry and cellular uptake on Caco-2 and cocultures of Caco-2\/HT29-MTX","volume":"92","author":"Li","year":"2017","journal-title":"Food Res. Int."},{"key":"10.1016\/j.lfs.2024.123245_bb0330","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1021\/acs.biomac.7b00011","article-title":"Oral nanomedicine based on multicomponent microemulsions for drug-resistant breast cancer treatment","volume":"18","author":"Qu","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.lfs.2024.123245_bb0335","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.carbpol.2018.11.099","article-title":"Self-assembled micelles based on N-octyl-N\u2019-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel","volume":"207","author":"Qu","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.lfs.2024.123245_bb0340","first-page":"784","article-title":"The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors","volume":"4","author":"Goebel","year":"2021","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.lfs.2024.123245_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415955","article-title":"A pan-cancer landscape of ABCG2 across human cancers: friend or foe?","volume":"23","author":"Lyu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0350","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00418-022-02106-z","article-title":"Interaction of crown ethers with the ABCG2 transporter and their implication for multidrug resistance reversal","volume":"158","author":"Mio\u010d","year":"2022","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.lfs.2024.123245_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100905","article-title":"ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance","volume":"66","author":"Fan","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.lfs.2024.123245_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105682","article-title":"Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway","volume":"119","author":"Nayak","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2024.123245_bb0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","article-title":"Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis","volume":"5","author":"Feng","year":"2018","journal-title":"Genes Dis."},{"key":"10.1016\/j.lfs.2024.123245_bb0370","article-title":"Subtypes of breast cancer","author":"Orrantia-Borunda","year":"2022","journal-title":"Breast Cancer [Internet]"},{"key":"10.1016\/j.lfs.2024.123245_bb0375","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000520871","article-title":"Expression of BCRP\/ABCG2 protein in invasive breast cancer and response to neoadjuvant chemotherapy","volume":"45","author":"Zhang","year":"2021","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.lfs.2024.123245_bb0380","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12282-020-01210-z","article-title":"Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer","volume":"28","author":"Nedeljkovi\u0107","year":"2021","journal-title":"Breast Cancer"},{"key":"10.1016\/j.lfs.2024.123245_bb0385","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.31557\/APJCP.2023.24.11.3891","article-title":"Association of ABCG2 polymorphisms on triple negative breast cancer (TNBC) susceptibility risk","volume":"24","author":"Ing","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.lfs.2024.123245_bb0390","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/1061186X.2022.2091578","article-title":"ABC transporters in breast cancer: their roles in multidrug resistance and beyond","volume":"30","author":"Modi","year":"2022","journal-title":"J. Drug Target."},{"key":"10.1016\/j.lfs.2024.123245_bb0395","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.3390\/ijms22063199","article-title":"Pleiotropic roles of ABC transporters in breast cancer","volume":"22","author":"He","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0400","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3390\/cancers14071732","article-title":"Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies","volume":"14","author":"Hossain","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2024.123245_bb0405","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3390\/ijms18091926","article-title":"Implications of ABCG2 expression on irinotecan treatment of colorectal cancer patients: a review","volume":"18","author":"Nielsen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310539","article-title":"ABCG2 gene and ABCG2 protein expression in colorectal cancer\u2014in silico and wet analysis","volume":"24","author":"Sa\u0142agacka-Kubiak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0415","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3892\/ol.2016.4937","article-title":"ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan","volume":"12","author":"Tuy","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2024.123245_bb0420","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1002\/jcp.26406","article-title":"Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis","volume":"233","author":"Hsu","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2024.123245_bb0425","first-page":"1","article-title":"ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cells","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.lfs.2024.123245_bb0430","article-title":"Dorsomorphin attenuates ABCG2-mediated multidrug resistance in colorectal cancer","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123245_bb0435","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3892\/or.2014.3470","article-title":"ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines","volume":"32","author":"Tang","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2024.123245_bb0440","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12931-017-0537-6","article-title":"ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling","volume":"18","author":"Vesel","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.lfs.2024.123245_bb0445","first-page":"2142","article-title":"Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer, thoracic","volume":"13","author":"Omori","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2024.123245_bb0450","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.bbmt.2016.05.002","article-title":"ABCG2, cytogenetics, and age predict relapse after allogeneic stem cell transplantation for acute myeloid leukemia in complete remission","volume":"22","author":"Damiani","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.lfs.2024.123245_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115930","article-title":"ABC transporters are predictors of treatment failure in acute myeloid leukaemia","volume":"170","author":"Cerovska","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2024.123245_bb0460","first-page":"6671","article-title":"Co-expression of ATP binding cassette transporters is associated with poor prognosis in acute myeloid leukemia","volume":"15","author":"Liu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2024.123245_bb0465","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3892\/or.2020.7915","article-title":"In vitro and ex vivo anti-tumor effect and mechanism of Tucatinib in leukemia stem cells and ABCG2-overexpressing leukemia cells","volume":"45","author":"Jing","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2024.123245_bb0470","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.3390\/ijms24087147","article-title":"ABCG2 in acute myeloid leukemia: old and new perspectives","volume":"24","author":"Damiani","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0475","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2012.075895","article-title":"Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy","volume":"98","author":"Tiribelli","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.lfs.2024.123245_bb0480","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/10428194.2016.1231405","article-title":"Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia","volume":"58","author":"Meg\u00edas-Vericat","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.lfs.2024.123245_bb0485","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.4081\/hr.2017.7406","article-title":"Expression of some ATP-binding cassette transporters in acute myeloid leukemia","volume":"9","author":"Salvia","year":"2017","journal-title":"Hematol. Rep."},{"key":"10.1016\/j.lfs.2024.123245_bb0490","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers13020217","article-title":"The role of tumor microenvironment in multiple myeloma development and progression","volume":"13","author":"Garc\u00eda-Ortiz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2024.123245_bb0495","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2147\/OTT.S195245","article-title":"The contribution of ABCG2 G34A and C421A polymorphisms to multiple myeloma susceptibility","volume":"12","author":"Niebudek","year":"2019","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.lfs.2024.123245_bb0500","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.3390\/ijms22136678","article-title":"The role of ABCG2 in the pathogenesis of primary hyperuricemia and gout-an update","volume":"22","author":"Eckenstaler","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0505","doi-asserted-by":"crossref","first-page":"667753","DOI":"10.3389\/fphar.2021.667753","article-title":"Function of uric acid transporters and their inhibitors in hyperuricaemia","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123245_bb0510","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10238-022-00848-7","article-title":"Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia","volume":"23","author":"P\u00e1link\u00e1s","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.lfs.2024.123245_bb0515","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nefroe.2022.11.015","article-title":"NRBP1 modulates uric acid transporter ABCG2 expression by activating the Wnt\/\u03b2-catenin pathway in HK-2 cells","volume":"43","author":"Zhang","year":"2023","journal-title":"Nefrolog\u00eda (English Edition)."},{"key":"10.1016\/j.lfs.2024.123245_bb0520","first-page":"135","article-title":"Pharmacogenetic perspective for optimal gout management, future","volume":"2","author":"Alrajeh","year":"2022","journal-title":"Pharmacology"},{"key":"10.1016\/j.lfs.2024.123245_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-019-1860-8","article-title":"The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients","volume":"21","author":"Stiburkova","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.lfs.2024.123245_bb0530","article-title":"Novel genetic loci in early-onset gout derived from whole genome sequencing of an adolescent gout cohort","author":"Ji","year":"2024","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.lfs.2024.123245_bb0535","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jcmgh.2019.06.006","article-title":"Porphyrin-induced protein oxidation and aggregation as a mechanism of porphyria-associated cell injury","volume":"8","author":"Maitra","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2024.123245_bb0540","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymgme.2019.01.020","article-title":"Erythropoietic protoporphyria and X-linked protoporphyria: pathophysiology, genetics, clinical manifestations, and management","volume":"128","author":"Balwani","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.lfs.2024.123245_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108487","article-title":"Protoporphyrin IX-induced phototoxicity: mechanisms and therapeutics","author":"Hussain","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2024.123245_bb0550","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw6127","article-title":"The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria","volume":"5","author":"Wang","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2024.123245_bb0555","article-title":"Roles of the ABCG2 transporter in protoporphyrin IX distribution and toxicity","author":"Qian Qi","year":"2024","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2024.123245_bb0560","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s13577-021-00534-y","article-title":"Porphyrin accumulation in humans with common dysfunctional variants of ABCG2, a porphyrin transporter: potential association with acquired photosensitivity","volume":"34","author":"Sakiyama","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.lfs.2024.123245_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22073742","article-title":"Disease-induced modulation of drug transporters at the blood\u2013brain barrier level","volume":"22","author":"Al Rihani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0570","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS."},{"key":"10.1016\/j.lfs.2024.123245_bb0575","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2024.123245_bb0580","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/pharmrev.120.000025","article-title":"ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery","volume":"75","author":"Schulz","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2024.123245_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166967","article-title":"Blood-brain barrier transporters: an overview of function, dysfunction in Alzheimer's disease and strategies for treatment","volume":"1870","author":"Chaves","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Basis Dis."},{"key":"10.1016\/j.lfs.2024.123245_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.111963","article-title":"ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells","volume":"210","author":"M\u00fcller","year":"2020","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.lfs.2024.123245_bb0595","article-title":"The impact of ATP-binding cassette transporters in the diseased brain: context matters","volume":"5","author":"Baltira","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.lfs.2024.123245_bb0600","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.bbagen.2018.07.021","article-title":"Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells","volume":"1862","author":"Shubbar","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"10.1016\/j.lfs.2024.123245_bb0605","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0041-1735541","article-title":"The function and expression of ATP-binding cassette transporters proteins in the Alzheimer\u2019s disease","volume":"8","author":"Aykac","year":"2021","journal-title":"Glob. Med. Gen."},{"key":"10.1016\/j.lfs.2024.123245_bb0610","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-170639","article-title":"ABC transporters are key players in Alzheimer\u2019s disease","volume":"61","author":"Pereira","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.lfs.2024.123245_bb0615","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s12035-020-02211-x","article-title":"The interplay of ABC transporters in A\u03b2 translocation and cholesterol metabolism: implicating their roles in Alzheimer\u2019s disease","volume":"58","author":"Behl","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2024.123245_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173009","article-title":"Therapeutic drugs modulate ATP-binding cassette transporter-mediated transport of amyloid beta (1\u201342) in brain microvascular endothelial cells","volume":"874","author":"Shubbar","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123245_bb0625","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2013.06.044","article-title":"Association between the ABCG2 C421A polymorphism and Alzheimer\u2019s disease","volume":"550","author":"Feh\u00e9r","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2024.123245_bb0630","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.lfs.2024.123245_bb0635","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fneur.2017.00301","article-title":"Drug-resistant epilepsy: multiple hypotheses, few answers","volume":"8","author":"Tang","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.lfs.2024.123245_bb0640","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.phrs.2019.04.031","article-title":"ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches","volume":"144","author":"Leandro","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2024.123245_bb0645","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2017.02.014","article-title":"Upregulation of breast cancer resistance protein and major vault protein in drug resistant epilepsy","volume":"47","author":"Dixit","year":"2017","journal-title":"Seizure"},{"issue":"1\u20138","key":"10.1016\/j.lfs.2024.123245_bb0650","article-title":"A systematic review and meta-analysis of the association of ABCC2\/ABCG2 polymorphisms with antiepileptic drug responses in epileptic patients","volume":"175","author":"Zan","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.lfs.2024.123245_bb0655","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.seizure.2022.03.009","article-title":"ABCG2, SCN1A and CYP3A5 genes polymorphism and drug-resistant epilepsy in children: a case-control study","volume":"97","author":"Mousavi","year":"2022","journal-title":"Seizure"},{"key":"10.1016\/j.lfs.2024.123245_bb0660","doi-asserted-by":"crossref","DOI":"10.1186\/s42269-019-0043-8","article-title":"Targeting multidrug resistance in cancer by natural chemosensitizers","volume":"43","author":"Hamed","year":"2019","journal-title":"Bull. Natl. Res. Cent."},{"key":"10.1016\/j.lfs.2024.123245_bb0665","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.3390\/molecules25153364","article-title":"Overcoming multidrug resistance: flavonoid and terpenoid nitrogen-containing derivatives as ABC transporter modulators","volume":"25","author":"Gon\u00e7alves","year":"2020","journal-title":"Molecules (Basel, Switzerland)."},{"key":"10.1016\/j.lfs.2024.123245_bb0670","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejphar.2014.11.021","article-title":"Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells","volume":"746","author":"Sato","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123245_bb0675","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/S0959-8049(22)01073-5","article-title":"The ABCB1\/ABCG2 inhibitor elacridar is a more potent pharmacoenhancer compared to tariquidar for treatment of intracranial tumors with small molecule drugs","volume":"174","author":"Van Tellingen","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lfs.2024.123245_bb0680","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ijc.11528","article-title":"Reversal of breast cancer resistance protein (BCRP\/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic","volume":"108","author":"Shiozawa","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2024.123245_bb0685","doi-asserted-by":"crossref","first-page":"115031","DOI":"10.1016\/j.bcp.2022.115031","article-title":"Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines","volume":"200","author":"Mansi","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123245_bb0690","doi-asserted-by":"crossref","DOI":"10.1002\/hlca.202200171","article-title":"Synthesis of the multidrug reversal agent Ko143 and its parent natural product fumitremorgin C","volume":"106","author":"Zechner","year":"2023","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.lfs.2024.123245_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112133","article-title":"Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP)","volume":"191","author":"Antoni","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2024.123245_bb0700","doi-asserted-by":"crossref","first-page":"723","DOI":"10.21873\/anticanres.15530","article-title":"Ko143 reverses MDR in glioblastoma via deactivating P-glycoprotein, sensitizing a resistant phenotype to TMZ treatment","volume":"42","author":"Lustig","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lfs.2024.123245_bb0705","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12185-020-03000-x","article-title":"The BCRP inhibitor febuxostat enhances the effect of nilotinib by regulation of intracellular concentration","volume":"113","author":"Ito","year":"2021","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.lfs.2024.123245_bb0710","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fphar.2016.00518","article-title":"Identification of febuxostat as a new strong ABCG2 inhibitor: potential applications and risks in clinical situations","volume":"7","author":"Miyata","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123245_bb0715","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/cts.12809","article-title":"Febuxostat, but not allopurinol, markedly raises the plasma concentrations of the breast cancer resistance protein substrate rosuvastatin","volume":"13","author":"Lehtisalo","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.lfs.2024.123245_bb0720","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/jox13020014","article-title":"Natural products as a tool to modulate the activity and expression of multidrug resistance proteins of intestinal barrier","volume":"13","author":"Martins-Gomes","year":"2023","journal-title":"J. Xenobiotics."},{"key":"10.1016\/j.lfs.2024.123245_bb0725","doi-asserted-by":"crossref","first-page":"e0136694","DOI":"10.1371\/journal.pone.0136694","article-title":"Curcumin improves the tumoricidal effect of Mitomycin C by suppressing ABCG2 expression in stem cell-like breast cancer cells","volume":"10","author":"Zhou","year":"2015","journal-title":"PloS one."},{"key":"10.1016\/j.lfs.2024.123245_bb0730","first-page":"6869","article-title":"The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol","volume":"18","author":"Cho","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2024.123245_bb0735","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s12079-022-00692-0","article-title":"Quinacrine and curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A","volume":"17","author":"Nayak","year":"2023","journal-title":"J. Cell Commun. Signaling."},{"key":"10.1016\/j.lfs.2024.123245_bb0740","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3892\/or.2016.4813","article-title":"Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1\u03b1 in vitro","volume":"36","author":"Wang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2024.123245_bb0745","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S2707-3688(23)00001-8","article-title":"Ursolic acid induces apoptosis and autophagy of HCT-8\/5-FU cells","volume":"3","author":"Jinyan","year":"2022","journal-title":"J. Holist. Integr. Pharm."},{"key":"10.1016\/j.lfs.2024.123245_bb0750","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/acs.jnatprod.1c00584","article-title":"Sophoraflavanone G resensitizes ABCG2-overexpressing multidrug-resistant non-small-cell lung cancer cells to chemotherapeutic drugs","volume":"84","author":"Wu","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.lfs.2024.123245_bb0755","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.3390\/molecules25112576","article-title":"Quercetin inhibits lef1 and resensitizes docetaxel-resistant breast cancer cells","volume":"25","author":"Prieto-Vila","year":"2020","journal-title":"Molecules (Basel, Switzerland)."},{"key":"10.1016\/j.lfs.2024.123245_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2021.104849","article-title":"Melinjo seed extract stimulates intestinal ABCG2 expression to reduce serum uric acid levels in hyperuricemic rats","volume":"87","author":"Tamura","year":"2021","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.lfs.2024.123245_bb0765","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/antiox10040564","article-title":"Anti-inflammatory and anti-hyperuricemic effects of chrysin on a high fructose corn syrup-induced hyperuricemia rat model via the amelioration of urate transporters and inhibition of NLRP3 Inflammasome signaling pathway","volume":"10","author":"Chang","year":"2021","journal-title":"Antioxidants (Basel)."},{"key":"10.1016\/j.lfs.2024.123245_bb0770","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1021\/acs.jafc.2c01513","article-title":"Naringenin ameliorates hyperuricemia by regulating renal uric acid excretion via the PI3K\/AKT signaling pathway and renal inflammation through the NF-\u03baB signaling pathway","volume":"71","author":"Yang","year":"2023","journal-title":"J. Agric. Food Chem."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052400835X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052400835X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T23:52:38Z","timestamp":1743983558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052400835X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":154,"alternative-id":["S002432052400835X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123245","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of ABCG2 in health and disease: Linking cancer therapy resistance and other disorders","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123245"}}